| |
| |
|
| Insider
Information: |
Cooper Jeffrey H |
| Relationship: |
SVP, Chief Financial O... |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
41,089 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,641,718 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,089 |
|
|
| Total
Value |
$3,641,718 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
SVP, Chief Financial O... |
2012-05-14 |
41,089 |
2006-02-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,075 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2009-04-30 |
4 |
A |
$10.93 |
$15,916 |
D/D |
1,456 |
6,502 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
14,502 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2009-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
16,502 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2010-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,400 |
28,486 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2010-05-30 |
4 |
A |
$11.64 |
$17,478 |
D/D |
1,502 |
20,086 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2010-10-29 |
4 |
A |
$11.64 |
$3,770 |
D/D |
324 |
26,810 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-04-29 |
4 |
A |
$11.64 |
$18,223 |
D/D |
1,566 |
28,376 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
35,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-10-31 |
4 |
A |
$13.23 |
$3,016 |
D/D |
228 |
40,104 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-04-30 |
4 |
A |
$19.35 |
$19,056 |
D/D |
985 |
41,089 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-02-27 |
4 |
AS |
$13.25 |
$13,250 |
D/D |
(1,000) |
0 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-03-01 |
4 |
AS |
$13.25 |
$205,375 |
D/D |
(15,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-03-16 |
4 |
AS |
$14.85 |
$185,625 |
D/D |
(12,500) |
0 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Chief Financial Officer |
• – – |
2006-08-29 |
4 |
AS |
$16.00 |
$416,000 |
D/D |
(26,000) |
0 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-12-06 |
4 |
AS |
$18.00 |
$261,000 |
D/D |
(14,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-08-08 |
4 |
AS |
$21.00 |
$262,500 |
D/D |
(12,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-09-06 |
4 |
AS |
$22.50 |
$304,560 |
D/D |
(13,536) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-09-26 |
4 |
AS |
$24.50 |
$306,250 |
D/D |
(12,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-10-08 |
4 |
AS |
$26.00 |
$321,880 |
D/D |
(12,380) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2010-10-25 |
4 |
AS |
$24.00 |
$365,016 |
D/D |
(15,209) |
26,486 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2010-10-29 |
4 |
AS |
$25.00 |
$727,865 |
D/D |
(28,750) |
26,486 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2010-11-24 |
4 |
AS |
$27.50 |
$309,375 |
D/D |
(11,250) |
26,810 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-05-26 |
4 |
AS |
$27.50 |
$481,250 |
D/D |
(17,500) |
37,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-07-01 |
4 |
AS |
$27.50 |
$68,750 |
D/D |
(2,500) |
39,876 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
